姜黄素在非小细胞肺癌治疗中的前景
The Prospects of Curcumin in Non-Small Cell Lung Cancer Therapeutics.
作者信息
Papavassiliou Kostas A, Sofianidi Amalia A, Gogou Vassiliki A, Papavassiliou Athanasios G
机构信息
First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
出版信息
Cancers (Basel). 2025 Jan 27;17(3):438. doi: 10.3390/cancers17030438.
Abstract
Lung cancer is the leading cause of cancer-related mortality worldwide, being responsible for approximately 2 million deaths in 2022 [...].
摘要
肺癌是全球癌症相关死亡的主要原因，2022年约有200万人死于肺癌[...]。
相似文献
1
The Prospects of Curcumin in Non-Small Cell Lung Cancer Therapeutics.姜黄素在非小细胞肺癌治疗中的前景
Cancers (Basel). 2025 Jan 27;17(3):438. doi: 10.3390/cancers17030438.
2
Curcumin-loaded liposomes modulating the synergistic role of EpCAM and estrogen receptor alpha in lung cancer management.载姜黄素脂质体调节 EpCAM 和雌激素受体α在肺癌治疗中的协同作用。
Pathol Res Pract. 2024 May;257:155317. doi: 10.1016/j.prp.2024.155317. Epub 2024 Apr 17.
3
Premature mitochondrial senescence and related ultrastructural changes during lung carcinogenesis modulation by curcumin and resveratrol.姜黄素和白藜芦醇调节肺癌发生过程中过早的线粒体衰老及相关超微结构变化。
Ultrastruct Pathol. 2012 May;36(3):179-84. doi: 10.3109/01913123.2011.652765.
4
Mortality by cause for eight regions of the world: Global Burden of Disease Study.世界八个地区按病因划分的死亡率：全球疾病负担研究
Lancet. 1997 May 3;349(9061):1269-76. doi: 10.1016/S0140-6736(96)07493-4.
5
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率：全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
6
Liposomal encapsulated curcumin attenuates lung cancer proliferation, migration, and induces apoptosis.脂质体包裹的姜黄素可减弱肺癌的增殖、迁移并诱导其凋亡。
Heliyon. 2024 Sep 25;10(19):e38409. doi: 10.1016/j.heliyon.2024.e38409. eCollection 2024 Oct 15.
7
Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction.姜黄素通过微小RNA-30c介导的MTA1表达下调增加耐紫杉醇非小细胞肺癌细胞对紫杉醇的敏感性。
Tumour Biol. 2017 Apr;39(4):1010428317698353. doi: 10.1177/1010428317698353.
8
Cytotoxic and apoptotic effects of the combination of palladium (II) 5,5-diethylbarbiturate complex with bis(2-pyridylmethyl)amine and curcumin on non small lung cancer cell lines.钯（II）5,5 - 二乙基巴比妥酸酯与双（2 - 吡啶甲基）胺及姜黄素的组合对非小细胞肺癌细胞系的细胞毒性和凋亡作用
Bioorg Med Chem. 2017 Mar 1;25(5):1717-1723. doi: 10.1016/j.bmc.2017.01.043. Epub 2017 Jan 28.
9
Translating curcumin to the clinic for lung cancer prevention: evaluation of the preclinical evidence for its utility in primary, secondary, and tertiary prevention strategies.将姜黄素应用于肺癌预防的临床转化：评估其在一级、二级和三级预防策略中效用的临床前证据。
J Pharmacol Exp Ther. 2014 Sep;350(3):483-94. doi: 10.1124/jpet.114.216333. Epub 2014 Jun 17.
10
Curcumin induces apoptosis and inhibits growth of orthotopic human non-small cell lung cancer xenografts.姜黄素诱导原位人非小细胞肺癌异种移植物凋亡并抑制其生长。
J Nutr Biochem. 2014 Aug;25(8):843-50. doi: 10.1016/j.jnutbio.2014.03.014. Epub 2014 Apr 13.
本文引用的文献
1
Curcumin Derivatives in Medicinal Chemistry: Potential Applications in Cancer Treatment.姜黄素衍生物在药物化学中的应用：在癌症治疗中的潜在应用。
Molecules. 2024 Nov 12;29(22):5321. doi: 10.3390/molecules29225321.
2
Curcumin and Baicalin Co-Loaded Nanoliposomes for Synergistic Treatment of Non-Small Cell Lung Cancer.姜黄素和黄芩苷共载纳米脂质体用于非小细胞肺癌的协同治疗
Pharmaceutics. 2024 Jul 23;16(8):973. doi: 10.3390/pharmaceutics16080973.
3
Curcumin suppresses copper accumulation in non-small cell lung cancer by binding ATOX1.姜黄素通过结合 ATOX1 抑制非小细胞肺癌中的铜积累。
BMC Pharmacol Toxicol. 2024 Aug 21;25(1):54. doi: 10.1186/s40360-024-00784-0.
4
Top advances of the year: Targeted therapy for lung cancer.年度重大进展：肺癌靶向治疗。
Cancer. 2024 Oct 1;130(19):3239-3250. doi: 10.1002/cncr.35423. Epub 2024 Jun 21.
5
Copper homeostasis and cuproptosis in cancer immunity and therapy.铜稳态与铜死亡在癌症免疫与治疗中的作用
Immunol Rev. 2024 Jan;321(1):211-227. doi: 10.1111/imr.13276. Epub 2023 Sep 16.
6
Pharmacological Mechanisms and Clinical Applications of Curcumin: Update.姜黄素的药理机制与临床应用：最新进展
Aging Dis. 2023 Jun 1;14(3):716-749. doi: 10.14336/AD.2022.1101.
7
Cell death regulation: A new way for natural products to treat osteoporosis.细胞死亡调控：天然产物治疗骨质疏松症的新途径。
Pharmacol Res. 2023 Jan;187:106635. doi: 10.1016/j.phrs.2022.106635. Epub 2022 Dec 26.
8
Curcumin Increased the Sensitivity of Non-Small-Cell Lung Cancer to Cisplatin through the Endoplasmic Reticulum Stress Pathway.姜黄素通过内质网应激途径增加非小细胞肺癌对顺铂的敏感性。
Evid Based Complement Alternat Med. 2022 Jun 17;2022:6886366. doi: 10.1155/2022/6886366. eCollection 2022.
9
Hallmarks of Cancer: New Dimensions.癌症的特征：新视角。
Cancer Discov. 2022 Jan;12(1):31-46. doi: 10.1158/2159-8290.CD-21-1059.
10
Curcumin increases crizotinib sensitivity through the inactivation of autophagy via epigenetic modulation of the miR-142-5p/Ulk1 axis in non-small cell lung cancer.姜黄素通过 miR-142-5p/Ulk1 轴的表观遗传调控抑制自噬从而增加非小细胞肺癌对克唑替尼的敏感性。
Cancer Biomark. 2022;34(2):297-307. doi: 10.3233/CBM-210282.
Zotero 插件